Clinical Cancer Research Landon Prizes for Basic and Translational Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dejmek, J.
Right arrow Articles by Andersson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dejmek, J.
Right arrow Articles by Andersson, T.
Clinical Cancer Research Vol. 11, 520-528, January 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Expression and Signaling Activity of Wnt-5a/Discoidin Domain Receptor-1 and Syk Plays Distinct but Decisive Roles in Breast Cancer Patient Survival

Janna Dejmek1, Karin Leandersson1, Jonas Manjer4, Anders Bjartell3, Stefan O. Emdin5, Wolfgang F. Vogel6, Göran Landberg2 and Tommy Andersson1

1 Experimental Pathology and 2 Pathology, Department of Laboratory Medicine and Departments of 3 Urology and 4 Community Medicine, Lund University, Malmö University Hospital, Malmö, Sweden; 5 Department of Surgery, Umeå University, Umeå, Sweden; and 6 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Requests for reprints: Tommy Andersson, Experimental Pathology, Department of Laboratory Medicine, Lund University, Malmö University Hospital, Entrance 78, SE-205 02 Malmö, Sweden. Phone: 46-40-337220; Fax: 46-40-337353; E-mail: tommy.andersson{at}exppat.mas.lu.se.

Purpose: The loss of Wnt-5a, a G-protein-coupled receptor ligand, or Syk, an intracellular kinase, has in separate studies been associated with poor prognosis of breast cancer patients. Both proteins are involved in cell adhesion, a key event in epithelial cancer metastasis. Here, we have investigated whether Syk is part of the Wnt-5a/discoidin domain receptor-1 (DDR1) signaling pathway and if a signaling interaction of these proteins is important for breast cancer–specific survival.

Experimental Design: The signaling interactions between Wnt-5a/DDR1 and Syk were addressed in mammary cell lines. Their mRNA and protein levels and the respective clinical correlates were investigated in 94 cases of primary breast cancer.

Results: The expression of Wnt-5a and Syk correlated in four of five tumor cell lines. However, despite a constitutive association between Syk and the Wnt-5a-dependent adhesion receptor DDR1, we found no evidence of a Wnt-5a/DDR1-mediated activation of Syk. Instead, ß1 integrins initiate the adhesion-induced activation of Syk. In tumors from breast cancer patients, the protein expression of Wnt-5a and Syk were differently regulated at the translational and transcriptional level, respectively. Analysis of breast cancer–specific survival revealed that the presence of Wnt-5a and Syk in primary tumors has good predictive value for a favorable outcome. Intriguingly, a simultaneous loss of both proteins did not reduce survival more than loss of either.

Conclusions: Despite the difference in regulation of Wnt-5a and Syk protein expression and their lack of signaling interaction, our clinical data indicate that a favorable prognosis in breast cancer requires the expression and signaling activity of both.

Key Words: cell adhesion • metastasis • prognostic factors




This article has been cited by other articles:


Home page
DevelopmentHome page
K. Roarty and R. Serra
Wnt5a is required for proper mammary gland development and TGF-{beta}-mediated inhibition of ductal growth
Development, November 1, 2007; 134(21): 3929 - 3939.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Luangdilok, C. Box, L. Patterson, W. Court, K. Harrington, L. Pitkin, P. Rhys-Evans, P. O-charoenrat, and S. Eccles
Syk Tyrosine Kinase Is Linked to Cell Motility and Progression in Squamous Cell Carcinomas of the Head and Neck
Cancer Res., August 15, 2007; 67(16): 7907 - 7916.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S Ripka, A Konig, M Buchholz, M Wagner, B Sipos, G Kloppel, J Downward, T. Gress, and P Michl
WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer
Carcinogenesis, June 1, 2007; 28(6): 1178 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. N. H. Masckauchan, D. Agalliu, M. Vorontchikhina, A. Ahn, N. L. Parmalee, C.-M. Li, A. Khoo, B. Tycko, A. M.C. Brown, and J. Kitajewski
Wnt5a Signaling Induces Proliferation and Survival of Endothelial Cells In Vitro and Expression of MMP-1 and Tie-2
Mol. Biol. Cell, December 1, 2006; 17(12): 5163 - 5172.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Leandersson, K. Riesbeck, and T. Andersson
Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells
Nucleic Acids Res., September 1, 2006; 34(14): 3988 - 3999.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. A. Noordeen, F. Carafoli, E. Hohenester, M. A. Horton, and B. Leitinger
A Transmembrane Leucine Zipper Is Required for Activation of the Dimeric Receptor Tyrosine Kinase DDR1
J. Biol. Chem., August 11, 2006; 281(32): 22744 - 22751.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Dejmek, A. Safholm, C. Kamp Nielsen, T. Andersson, and K. Leandersson
Wnt-5a/Ca2+-Induced NFAT Activity Is Counteracted by Wnt-5a/Yes-Cdc42-Casein Kinase 1{alpha} Signaling in Human Mammary Epithelial Cells.
Mol. Cell. Biol., August 1, 2006; 26(16): 6024 - 6036.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Pukrop, F. Klemm, Th. Hagemann, D. Gradl, M. Schulz, S. Siemes, L. Trumper, and C. Binder
Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines
PNAS, April 4, 2006; 103(14): 5454 - 5459.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Safholm, K. Leandersson, J. Dejmek, C. K. Nielsen, B. O. Villoutreix, and T. Andersson
A Formylated Hexapeptide Ligand Mimics the Ability of Wnt-5a to Impair Migration of Human Breast Epithelial Cells
J. Biol. Chem., February 3, 2006; 281(5): 2740 - 2749.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Matsuyama, M. Watanabe, Y. Shirahama, R. Hirano, H. Mitsuyama, I. Higashimoto, M. Osame, and K. Arimura
Suppression of Discoidin Domain Receptor 1 by RNA Interference Attenuates Lung Inflammation
J. Immunol., February 1, 2006; 176(3): 1928 - 1936.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Zyss, P. Montcourrier, B. Vidal, C. Anguille, F. Merezegue, A. Sahuquet, P. H. Mangeat, and P. J. Coopman
The Syk Tyrosine Kinase Localizes to the Centrosomes and Negatively Affects Mitotic Progression
Cancer Res., December 1, 2005; 65(23): 10872 - 10880.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Wang, E. Devarajan, J. He, S. P. Reddy, and J. L. Dai
Transcription Repressor Activity of Spleen Tyrosine Kinase Mediates Breast Tumor Suppression
Cancer Res., November 15, 2005; 65(22): 10289 - 10297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.